Commentary

Video

Safety Data With Ponatinib in PHALLCON for Ph+ Acute Lymphoblastic Leukemia

Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss safety findings from the PHALLCON trial of ponatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia.

Video Player is loading.
Current Time 0:00
Duration 4:00
Loaded: 0%
Stream Type LIVE
Remaining Time 4:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected